Treatment for primary liver cancer – initial experience with a new device in a Brazilian Cancer Center

Phase 2

Completed

• Conditions: Primary liver cancer; Cancer

• Registration Number: ISRCTN16295622
• Lead Sponsor: INCA - Brazilian National Cancer Institute

Brief Summary

2017 results in: https://www.ncbi.nlm.nih.gov/pubmed/28166821

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2010-12-01
• Study Start: 2016-10-14
• Last Update Posted: 25 March 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

1. Patients 18 years old or above
2. Present with a Child A or B (Child-Pugh Classification) score
3. A PS equal or less than 2
4. A liver tumor compatible with a Barcelona clinic liver cancer (BCLC) stage B or C HCC which had not been previously submitted to transcatheter arterial chemoembolization (TACE) or any intra-arterial treatment

Exclusion Criteria

1. Performance status scale (PS - Karnofsky performance status scale) of 2 or less
2. No extrahepatic spread of the liver tumor
3. Child-Pugh classification A or B
4. 17 years of age or younger
5. Refusal to sign the Informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified